Chinese patent medicines "seize" the retail market of cough medicines, and many varieties grow against the trend

Affected by the new crown epidemic in 2020, many industries have been affected.
As the physical pharmacy at the forefront of epidemic prevention and control, the sales of antipyretic, cough, antiviral and other drugs are also strictly controlled
.
In the retail market of cough medicines, 40% of the varieties contribute more than 60% of the market, and Chinese patent medicines have an absolute advantage
.
Proprietary Chinese medicine has an absolute advantage in cough medicine Cough is a common symptom of respiratory diseases, more common in common colds and respiratory tract infections.
In addition, acute and chronic bronchitis, pneumonia, asthma, rhinitis, etc.
are also common causes of cough
.
Drugs used to treat coughs account for about 5% of retail pharmacies and are one of the commonly used drugs
.
Since the epidemic, the sales of most varieties of cough medicines have declined due to the supervision
.
On the other hand, the epidemic has promoted the vigorous development of online drug purchases, which has changed the daily habits of patients to purchase drugs in pharmacies, and also has a certain impact on offline drug sales
.
At the physical pharmacy terminals in key cities, the ratio of Chinese patent medicines and chemical drugs for cough medicine is about 9:1.
Affected by the epidemic, the sales of Chinese patent medicines and chemical medicines for cough relief will decline in 2020, but the ratio of the two types is not large.
changes
.
From 2017 to 2021, the sales growth of cough medicines in physical pharmacies in key cities E (unit: 100 million yuan) Data source: 40% of the terminal competition pattern of physical pharmacies in key cities of Minet.
com Market data shows that from 2017 to 2019 Among the cough medicines, the number of varieties with sales growth accounted for about 40%, and the market contribution rate reached 60 to 70%.
During the epidemic in 2020, sales of 15.
5% of the varieties still maintained growth, and the cough medicine market contributed 19.
1% share
.
In 2021, with the normalization of epidemic prevention and control, the restart of the retail market, and the opening of sales restrictions, it is expected that the sales of most cough medicine brands will rebound.

.
2017-2021 E key city brick-and-mortar pharmacies grow in the number of varieties and sales ratio of cough medicines Source: Minet.
com Key city brick-and-mortar pharmacies terminal competition pattern Affected by the epidemic in 2020, the five major cough-relieving varieties that are still growing are Tiepi Fengdou Granules, Bufei Pills, Dextromethorphan Guaifenesin Syrup, Bushen Runfei Oral Liquid, and Yangyin Qingfei Ointment.
A Chinese patent medicine for nourishing Qi and nourishing lungs
.
Tiepi Fengdou Granules has grown steadily in the past five years, and it has not been affected by the epidemic.
It has become the first in sales of cough medicines, but this medicine is a regional variety and is mainly sold in Zhejiang
.
Tiepi Fengdou Granules is a Chinese patent medicine that promotes fluid and relieves cough, tonifies deficiency and replenishes qi.
It can improve the immunity of patients while treating dry cough, so that patients with weak constitution and mental fatigue have a beneficial effect.
It is also suitable for patients in the new crown epidemic
.
In addition, the compound growth rate of Bufei Pills for Bufei Yiqi in the past five years has exceeded 30%, and sales in 2021 are expected to be the same as in 2020
.
In 2020, the sales growth of physical pharmacies in key cities and the top 5 varieties of cough medicines Data source: Minet.
com The competitive landscape of physical pharmacies in key cities The retail market will usher in new opportunities.
"Guiding Opinions on Carrying out "Internet +" Medical Insurance Services During the Period of Pneumonia Epidemic Prevention and Control", and actively opening up the medical insurance payment channel for Internet medical care will not only help reduce the risk of cross-infection when the masses seek medical treatment and purchase drugs, but also enjoy the convenient service of online medical insurance settlement
.
In addition, B2C, O2O and other online platforms related to "Internet +" have also developed rapidly, among which O2O has become the mainstream "Internet +" online drug purchase channel during the epidemic
.
Based on the distribution range of physical stores, O2O connects the "last mile" between pharmacies and patients, and quickly solves the problem of drug purchases for patients
.
The integration of online and offline channels of drug retailing will bring more convenience to patients, and the market will usher in new opportunities
.
Source: Minet database Note: The database of the terminal competition pattern of physical pharmacies in key cities is a sample city drug sales database that continuously monitors all categories based on the sales data of all physical pharmacies in 22 key cities
.
22 key cities include: Beijing, Guangzhou, Harbin, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Nanning, Ningbo, Qingdao, Shanghai, Shenzhen, Shenyang, Shijiazhuang , Tianjin, Wuhan, Xi'an, Yangzhou, Changchun, Changsha, Chongqing